Medimar SA was founded in 1979 by Lázaro Marinos with rapid development thanks to the introduction of innovative methods in the pharmaceutical market, which as a result established a prominent position in the field of dermatology.
In 1982, Medimar began the production of revolutionary dermatological products, thus offering solutions to chronic diseases. With knowledge, continuous research and collaboration with leading research centers and scientists, they have launched products with unique compositions that are aimed at the pharmaceutical market and hospitals.
In 2001, the company bought drugs from Boehringer Ingelheim and moved to a broader pharmaceutical market, creating a network throughout Greece.
Since 2003, Medimar SA has established a Department of Respiratory Devices that provides reliable solutions and services to patients with Chronic Obstructive Pulmonary Disease (COPD) and Sleep Apnea Syndrome and operates 24 hours a day, 365 days a year.
Medimar SA works with absolute dedication in order to provide high-level services and products and for this reason, its operations comply with the Principles of Total Quality Management and the Quality Requirements of the International Standards ISO 9001: 2008.
The ultimate goal of the company is to earn the trust of the medical world and patients on a daily basis.